|
|
|
|
![]() |
| 3B3-027677 |
|
4-7-10-13-16 Docsapentaenoic acid |
| 3B3-027678 |
|
6C,9C,12C,15C-Octadecatetraenoic acid |
| 3B3-027679 |
|
9-Oxo-15R-hydroxy-15-hethyl-prosta-5Z,10,13E-trien-1-oic acid |
| 3B3-027680 |
|
9alpha,15S-dihydroxy-11-oxo-prost-13E-en-1-oic acid |
| 3B3-027681 |
|
1,-9alpha,15S-trihydroxy-prost-13E-en-11-one |
| 3B3-027682 |
|
(4S)-(3-[(3R,S)-3-Cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidine-heptanoic acid |
| 3B3-027683 |
|
9alpha,15R-Dihydroxy-11-oxo-15-methyl-prosta-5Z,13E-dien-1-oic acid |
| 3B3-027684 |
|
9alpha,15S-Dihydroxy-11-oxo-15-methyl-prosta-5Z,13E-dien-1-oic acid |
| 3B3-027685 |
|
9alpha,15R-Dihydroxy-11-oxo-16,16-dimethyl-prosta-5Z,13E-dien-1-oic acid |
| 3B3-027686 |
|
9alpha,15S-Dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid |
| 3B3-027687 |
|
Delta17-prostaglandin E1 |
| 3B3-027688 |
|
11-Deoxy-13,14-dihydro-15-keto-11beta,16chi-cycloprostaglanin E1 |
| 3B3-027689 |
|
6,9-Dioxo-11alpha,15R-dihydroxy-16,16-dimethyl-prost-13E-en-1-oic acid |
| 3B3-027690 |
|
9-Oxo-11alpha,15R-dihydroxy-15-methyl-prosta-5Z,13E-dien-1-oic acid |
| 3B3-027691 |
|
9-Oxo-11alpha,15S-dihydroxy-15-methyl-prosta-5Z,13E-dien-1-oic acid |
| 3B3-027692 |
|
Sulprostone |
| 3B3-027693 |
|
9-Oxo-11alpha,15S,20-trihydroxy-prosta-5Z,13E-dien-1-oic acid |
| 3B3-027694 |
|
9-Oxo-11alpha,15S-dihydroxy-prosta-5Z,13E,17E-trien-1-oic acid |
| 3B3-027695 |
|
1,9alpha,11alpha,15S-tetrahydroxy-prost-13E-ene |
| 3B3-027696 |
|
6-Oxo-9alpha,11alpha,15S-trihydroxy-prosta-13E,17Z-dien-1-oic aicd |
| |
|
|
| |
|
|
| |
|
Home Previous 1486 1487 1488 1489 1490 Next End |
|
|
| |
|
| Home - About Us - Contact Us - Bookmark |
|
 |
| Copyright @ 2021 3bsc.com Inc. All Rights Reserved |
| ¶õICP±¸2021000677ºÅ |
 ¶õ¹«Íø°²±¸ 42011102004317ºÅ |
|
|
